VEGF-D can modulate angiogenesis in an NP-1-dependent fashion as well, with NP-1 either acting as a co-receptor for efficient receptor activation or by NP-1-mediated phosphorylation of downstream VEGFR-2 effectors in breast and other cancers [60,61]. Here, KDR is linked to cancer.